Advanced Biomedical Technologies, Inc.
ABMT · OTC
10/31/2022 | 10/31/2021 | 10/31/2020 | 10/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 58.3% | 38.5% | 960.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 81.9% | 54.5% | 58.1% | 34.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -61.3% | -214.6% | -228.7% | -5,158% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -190.2% | -426.1% | -543.7% | -8,139.5% |
| EPS Diluted | -0.007 | -0.01 | -0.01 | -0.01 |
| % Growth | 29.8% | -8.3% | 4% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$0 |